Acquisition of a powerful NMR spectrometer for small-molecule chemistry
Acquisition of a 500 MHz NMR Spectrometer to Support Small-Molecule Chemistry at Johns Hopkins Medical School
['FUNDING_OTHER'] · JOHNS HOPKINS UNIVERSITY · NIH-10852022
This study is all about getting a super advanced NMR machine to help scientists at Johns Hopkins better understand small molecules that play a big role in diseases like cancer, making their research more effective and accurate for everyone involved.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10852022 on ClinicalTrials.gov |
What this research studies
This project aims to acquire a state-of-the-art 500 MHz NMR spectrometer to enhance the capabilities of researchers at Johns Hopkins School of Medicine. The new equipment will support a wide range of NIH-funded studies focusing on small molecules, which are crucial for understanding various diseases, including cancers. By providing advanced tools for molecular characterization, the research will facilitate the work of scientists across multiple clinical and basic science departments. This initiative is expected to improve the efficiency and accuracy of research outcomes.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients with conditions that are being studied through small-molecule therapies, particularly those related to cancer and other serious diseases.
Not a fit: Patients who are not involved in studies utilizing small molecules or those with conditions unrelated to the research focus may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in the understanding and treatment of various diseases through improved small-molecule analysis.
How similar studies have performed: Other research utilizing advanced NMR spectroscopy has shown success in enhancing drug development and understanding molecular interactions, indicating that this approach is well-established and promising.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BHAT, SHRIDHAR — JOHNS HOPKINS UNIVERSITY
- Study coordinator: BHAT, SHRIDHAR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers